<DOC>
	<DOC>NCT01779258</DOC>
	<brief_summary>The purpose of this study is to confirm that emollients play a major role in the maintenance therapy after clearing of inflammatory lesions and can reduce occurrence of flares in children with atopic dermatitis.</brief_summary>
	<brief_title>Emollients in the Management of Atopic Dermatitis</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis, Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Desonide</mesh_term>
	<mesh_term>Glycerol</mesh_term>
	<mesh_term>Emollients</mesh_term>
	<criteria>Age between 2 and 6 years included, Presenting with atopic dermatitis, with at least one duly documented flare treated by corticosteroids within the previous 6 months, and presenting a current flare (objective Scoring for Atopic Dermatitis (SCORAD score) is [1540] at inclusion), After treatment of the current flare, patients should have for randomization an Objective SCORAD score &lt; 15, with Xerosis intensityâ‰¥ 1 and no subjective signs Severe form of atopic dermatitis requiring either systemic corticosteroid treatment and/or antibiotic or antiviral treatment and/or hospitalisation, Primary bacterial, viral, fungal or parasitic skin infection, Ulcerated lesions, acne or rosacea, Dermatological disease other than atopic dermatitis which could interfere with the assessment, Immunosuppression,</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>xerosis</keyword>
	<keyword>dry skin</keyword>
	<keyword>dermatitis</keyword>
	<keyword>eczema</keyword>
	<keyword>emollient</keyword>
	<keyword>corticosteroid</keyword>
	<keyword>flare</keyword>
</DOC>